Ironwood Pharmaceuticals, Inc. (IRWD)
4.87
+0.02
(+0.41%)
USD |
NASDAQ |
Nov 13, 10:00
Ironwood Pharmaceuticals Price : 4.87 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 4.83 | 4.995 | 4.79 | 4.85 | 3.569M |
| Nov 11, 2026 | 4.81 | 4.93 | 4.74 | 4.87 | 2.821M |
| Nov 10, 2026 | 4.68 | 4.968 | 4.65 | 4.81 | 4.594M |
| Nov 09, 2026 | 4.50 | 4.76 | 4.345 | 4.68 | 5.331M |
| Nov 06, 2026 | 4.26 | 4.44 | 4.10 | 4.39 | 3.963M |
| Nov 05, 2026 | 4.30 | 4.41 | 3.84 | 4.03 | 4.989M |
| Nov 04, 2026 | 3.61 | 3.80 | 3.58 | 3.77 | 2.572M |
| Nov 03, 2026 | 3.51 | 3.57 | 3.40 | 3.50 | 1.947M |
| Nov 02, 2026 | 3.50 | 3.585 | 3.433 | 3.46 | 1.300M |
| Oct 30, 2026 | 3.59 | 3.64 | 3.45 | 3.50 | 1.471M |
| Oct 29, 2026 | 3.65 | 3.695 | 3.575 | 3.62 | 1.368M |
| Oct 28, 2026 | 3.46 | 3.63 | 3.46 | 3.61 | 1.411M |
| Oct 27, 2026 | 3.52 | 3.545 | 3.45 | 3.51 | 1.656M |
| Oct 26, 2026 | 3.49 | 3.535 | 3.45 | 3.50 | 1.131M |
| Oct 23, 2026 | 3.52 | 3.536 | 3.38 | 3.46 | 1.261M |
| Oct 22, 2026 | 3.50 | 3.605 | 3.49 | 3.57 | 1.041M |
| Oct 21, 2026 | 3.68 | 3.69 | 3.521 | 3.55 | 1.519M |
| Oct 20, 2026 | 3.57 | 3.71 | 3.525 | 3.63 | 1.641M |
| Oct 19, 2026 | 3.53 | 3.59 | 3.475 | 3.56 | 1.679M |
| Oct 16, 2026 | 3.73 | 3.73 | 3.48 | 3.50 | 2.531M |
| Oct 15, 2026 | 3.63 | 3.87 | 3.63 | 3.77 | 2.045M |
| Oct 14, 2026 | 3.55 | 3.63 | 3.51 | 3.60 | 1.223M |
| Oct 13, 2026 | 3.74 | 3.78 | 3.545 | 3.59 | 2.106M |
| Oct 12, 2026 | 3.82 | 3.85 | 3.74 | 3.76 | 1.036M |
| Oct 09, 2026 | 3.88 | 3.95 | 3.81 | 3.82 | 1.722M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Xencor, Inc. | 37.08 |
| Viking Therapeutics, Inc. | 27.22 |
| IDEAYA Biosciences, Inc. | 30.69 |
| BioMarin Pharmaceutical, Inc. | 56.72 |
| Inovio Pharmaceuticals, Inc. | 1.42 |
Price Related Metrics
| PE Ratio | 5.452 |
| PS Ratio | 2.021 |
| PEG Ratio | 0.0108 |
| Price to Free Cash Flow | 3.939 |
| Earnings Yield | 18.34% |
| Market Cap | 806.23M |
| PEGY Ratio | 0.0108 |
| Operating PE Ratio | 3.216 |
| Normalized PE Ratio | 5.460 |